HROW Insider Trading

Insider Ownership Percentage: 13.67%
Insider Buying (Last 12 Months): $1,864,011.35
Insider Selling (Last 12 Months): $0.00

Harrow Insider Trading History Chart

This chart shows the insider buying and selling history at Harrow by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1M-$500k$0$500k$1MTotal Insider BuyingTotal Insider Selling

Harrow Share Price & Price History

Current Price: $28.08
Price Change: Price Increase of +0.52 (1.89%)
As of 02/28/2025 05:00 PM ET

This chart shows the closing price history over time for HROW up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AprMayJunJulAugSepOctNovDecJanFeb$28.08Closing price on 02/28/25:

SEC Filings (Institutional Ownership Changes) for Harrow (NASDAQ:HROW)

72.76% of Harrow stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HROW by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$54Mbought$51MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$40M-$20M$0$20M$40MTotal InflowsTotal Outflows
Harrow logo
Harrow, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in Nashville, Tennessee.
Read More on Harrow

Today's Range

Now: $28.08
Low: $27.07
High: $28.25

50 Day Range

MA: $32.64
Low: $27.56
High: $36.67

52 Week Range

Now: $28.08
Low: $9.30
High: $59.23

Volume

200,504 shs

Average Volume

326,777 shs

Market Capitalization

$1.00 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69

Who are the company insiders with the largest holdings of Harrow?

Harrow's top insider shareholders include:
  1. Opaleye Management Inc (Major Shareholder)
  2. Mark L Baum (CEO)
  3. Martin A Makary (Director)
Learn More about top insider investors at Harrow.

Who are the major institutional investors of Harrow?

Harrow's top institutional shareholders include:
  1. Vanguard Group Inc. — 5.26%
  2. Private Capital Management LLC — 4.76%
  3. Braidwell LP — 2.55%
  4. Geode Capital Management LLC — 2.02%
  5. D. E. Shaw & Co. Inc. — 1.87%
  6. Stifel Financial Corp — 1.15%
Learn More about top institutional investors of Harrow stock.

Which institutional investors are selling Harrow stock?

In the last quarter, HROW stock was sold by these institutional investors:
  1. Private Capital Management LLC
  2. Nuveen Asset Management LLC
  3. JPMorgan Chase & Co.
  4. Invesco Ltd.
  5. Millennium Management LLC
  6. Bank of America Corp DE
  7. Assenagon Asset Management S.A.
  8. BNP Paribas Financial Markets

Which institutional investors are buying Harrow stock?

In the last quarter, HROW stock was acquired by institutional investors including:
  1. Braidwell LP
  2. HAP Trading LLC
  3. Two Sigma Investments LP
  4. Neuberger Berman Group LLC
  5. Squarepoint Ops LLC
  6. Caption Management LLC
  7. Jane Street Group LLC
  8. Trexquant Investment LP
Within the last year, these company insiders have bought Harrow stock:
  1. Opaleye Management Inc (Major Shareholder)
  2. Mark L Baum (CEO)
  3. Martin A Makary (Director)
Learn More investors buying Harrow stock.